While the pharmaceutical industry is relatively concentrated already, consolidation will continue in the future as companies struggle with high R&D costs and uncertain pipeline success rates. Drawing on its extensive experience guiding clients through uncertainty, and mergers and acquisitions, CAP partners with clients to ensure that executive compensation supports a successful close and integration process. CAP helps its pharmaceutical clients improve their ability to attract, retain, and motivate key executive talent in order to achieve their growth strategies. Learn more about CAP’s expertise in the pharmaceutical industry here or contact us for additional information.
Upcoming Events See All
May 17, 2024
Best Practices for Board Compensation
Washington D.C.
The newly updated results from our renowned and comprehensive Private Company Board Compensation survey, featuring data from more than 1,500 private and family-owned firms,…
May 21, 2024
Knowing When and How to Modify Your Long-Term Incentives
Cincinnati, OH
Effective, tailored incentive plans are critical to motivating employees and ensuring alignment with shareholder interests. High-performing organizations design long-term programs that complement the company's…
Jun 06, 2024
Where SEC Rule-Making, Shareholder Reporting, and Plan Design Collide
Boston, MA
The SEC has issued a flurry of new rules covering insider trading, clawbacks, proxy reporting, and more. These rules have plan design implications and,…